Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 593-594, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwok, P.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwok, P.-Y.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2000;46:593-594.)
© 2000 American Association for Clinical Chemistry, Inc.

Editorial

Finding a Needle in a Haystack: Detection and Quantification of Rare Mutant Alleles Are Coming of Age

Pui-Yan Kwok

Departments of Dermatology and Genetics, Washington University School of Medicine, 660 S. Euclid Ave., Box 8123, St. Louis, MO 63110, Fax 314-362-8159, E-mail kwok@genetics.wustl.edu

Detecting rare mutant alleles in the background of wild-type DNA sequences and quantifying a specific DNA sequence in a clinical sample are two of the most challenging problems in DNA diagnostics. Successful approaches can expect important applications. For example, prenatal diagnosis of genetic disorders can be accomplished by invasive procedures such as amniocentesis, chorionic villus sampling, or fetal blood sampling, or by labor-intensive methods such as fetal cell enrichment from maternal circulation (1). If one can detect the mutant allele in the small number of fetal cells found in the maternal circulation, prenatal diagnosis of many devastating genetic disorders can be done with a simple blood test that poses minimal risk to the mother or the fetus. Other applications of the ability to find "a needle in the haystack" include cancer marker detection for early diagnosis or detection of relapse (2), and detection of specific alleles in pooled population samples (3). Similarly, the ability to quantify the amount of a specific DNA species present in clinical samples can help define the viral load in HIV-positive patients (4), determine minimal residual disease in patients with leukemia (5)(6), and monitor specific gene expression (7).

In . . . [Full Text of this Article]


References




The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. Pathol.Home page
K. Sotlar, L. Escribano, O. Landt, S. Mohrle, S. Herrero, A. Torrelo, U. Lass, H.-P. Horny, and B. Bultmann
One-Step Detection of c-kit Point Mutations Using Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping and Hybridization Probes
Am. J. Pathol., March 1, 2003; 162(3): 737 - 746.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.